7Baggers
 published on: 2025-11-12 15:45:42  newser.com Wed, 12 Nov 2025 21:45:42 GMT
 Q1 Earnings Estimate for VTVT Issued By HC Wainwright  MarketBeat Mon, 10 Nov 2025 09:37:15 GMT
 published on: 2025-11-09 04:29:35  newser.com Sun, 09 Nov 2025 10:29:35 GMT
 VTv Therapeutics: Q3 Earnings Snapshot  theheraldreview.com Fri, 07 Nov 2025 11:09:10 GMT
 VTVT Achieves Key Milestones in Q3, Advances Cadisegliatin Progr  GuruFocus Thu, 06 Nov 2025 23:11:30 GMT
 vtv therapeutics reports q3 eps ($1.08), consensus (98c)  TipRanks Thu, 06 Nov 2025 23:02:15 GMT
 VTv Therapeutics: Q3 Earnings Snapshot  WRAL Thu, 06 Nov 2025 22:42:43 GMT
 vTv Therapeutics Q3 net loss widens to $8.7 mln  TradingView Thu, 06 Nov 2025 22:12:42 GMT
 published on: 2025-11-06 04:22:04  newser.com Thu, 06 Nov 2025 10:22:04 GMT
 published on: 2025-11-05 03:50:04  newser.com Wed, 05 Nov 2025 09:50:04 GMT
 published on: 2025-11-04 03:03:13  newser.com Tue, 04 Nov 2025 09:03:13 GMT
 published on: 2025-11-03 02:42:39  newser.com Mon, 03 Nov 2025 08:42:39 GMT
 published on: 2025-11-02 05:34:24  newser.com Sun, 02 Nov 2025 10:34:24 GMT
 published on: 2025-11-02 01:35:19  newser.com Sun, 02 Nov 2025 06:35:19 GMT

vTv Therapeutics Inc
(NASDAQ:VTVT) 

VTVT stock logo

vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates to fill unmet medical needs. The company is developing TTP399, an orally administered, small molecule, liver-selective glucokinase activator for the tr...

Founded: 2015
Full Time Employees: 26
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends